Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Phac2g02896 ATGCCGCAAATAATGAGGTTTTCAACACTCGTAGTTGTGTTGCTTTTTTGTTTTTCTCCTACGCTTGTAGTCCTTGGTCTGGGCTACTCAGATCACACTACTTTGAGAGTGCTGTTGGAAGTGAAGAAGTCTTTTGTGCAAGACCCACGAAATGTTCTGAGTGATTGGTCAGAGGATAACATTGACTACTGCAGTTGGAGAGGGGTGTCATGTGAATTGAACTCAGACTCAAACTCAATTTCAAACTCTTTAGATGGTGACTCCATGCAAGTGGTGGGTCTCAATCTTTCTGACTCGTCACTCACCGGGTCAGTATCACCTTCACTCGGTCGTTTGAAAAACCTGCTCCACCTTGATCTCTCCTCCAACAGCCTCACAGGTCCCATTCCACCCAATCTCTCCAACCTCACTTCCTTGGAATCTTTGCTTCTCTTCTCCAACCAACTCACGGGTCACATACCCAAAGAGTTCGGCTCGCTCAAGAGTCTCCGAGTCATGCGACTCGGTGACAATGCATTAACGGGAAGGATTCCCGCTTCTCTAGCCAACCTGAATAATTTGGTCAACCTTGGCTTGGCTTCCTGCGGACTCACCGGGTCTATTCCAAGTCAACTTGGTCAACTCAAACTCATGGAGAATCTGATTCTGCAAGACAACGAGTTGATGGGTCCCATTCCGACCGAGTTAGGGAACTGCTCAAGCCTCACCATCTTCACTGCAGCTAACAACAAACTAAATGGATCAATTCCCAGTGAACTGGGTCGACTCAGCAATCTGCAAATTCTCAACTTTGCCAACAACAGTATATCAGGGAAGATTCCGAGTCAACTCGGTAATATGAGTCAACTCGTTTACCTGAACTTCATGGGGAACCAGCTCGAGGGTACCATTCCACCGTCTCTAGCTCAACTGGGCAATCTTCAAAATCTGGACTTCTCAATGAACAATTTCAGTGGAGGAATCCCAGAGGAGTTAGGCAACTTGGGTGAGCTAGCTTATTTGGTTCTGTCTGGTAACAACCTTAATGGCGTCATACCAAGGACCATATGTTCCAATGCTACTAGTTTGGAGCACTTGATGTTATCAGAAAGTGGACTTCATGGTGAGATTCCAGCTGAGTTGAGTCAATGCCAGCAACTGATGCAACTTGATTTGTCCAACAATGCACTCAACGGGTCCATACCTCTTGAGCTTTATGGGTTGCTGCGGTTAACTGATCTCCTCCTGAACAATAACAGCTTGGTTGGTTCCATCTCTCCCTTCATAGGGAACCTCAGTGGCTTGCAGACCCTTGCTTTGTTTCACAATAATTTGGAGGGTGTTCTGCCGAGAGAGATTGGAATGCTGGGCAAGTTGGAAATTTTGTATCTTTATGATAACCAATTGTCTGGGGCAATACCTGTGGGGATTGGTAATTGTTCTAGCTTGCAAATGATTGATTTTTTTGGAAACCGTTTCAGTGGGGAAATTCCCGTCACTATTGGAAGGCTGAAAGAGTTGAATTTCCTTCACCTTCGACAGAATGAGCTAGTGGGTGCGATTCCAGCAACCTTGGGTAATTGTCATAAACTGAACATTCTGGATTTGGCTGACAATCAGCTCTCAGGTGCAATTCCTGCAACGTTTGGATTCCTCAAGGAATTACAGCAACTCATGCTCTACAACAATTCCCTGGAAGGTAATCTCCCTCACCAACTGATAACTGTAGCAAACTTGACCAGAGTGAATCTTTCTAAGAACAGATTGAATGGTAGTATAGCTGCATTGTGTAGCTCTCAATCATTTCTTTCTTTCGATGTTACTGACAATGAGTTTGATGGTGAAATTCCTTCCCAAATGGGAAACTCACCCTCCCTTGAGAGACTAAGATTAGGTAACAATAAATTTTCTGGAGAAATTCCAAGGACATTGGGAAAAATCCGTGACCTGTCATTGTTAGACCTCTCTGGAAATTCACTCACTGGACCAATACCAGCTGAGCTTTCTTTGTGCAACAAACTGGCTTATATTGATTTGAACAGTAATTTCCTTTTCGGACAAATACCATCATGGCTTGGAAGTTTGTCTGAGTTGGGAGAGCTAAAGCTCTCCTCCAATAATTTTTCTGGGCCACTTCCATTAGGCCTATTCAAATGTTCTAAGTTGCTAGTTCTCTCTCTAAATGACAACTCCCTGAATGGAAGTCTCCCATCCGATATTGGTGAACTTGCAAACCTCAATGTCCTCAGACTTGACCGCAATAAGTTTTCTGGACCAATCCCTTTGGAGATAGGGAAGTTGATCAAGCTTTATGAGCTCCGACTCTCCAGAAATGGATTCCATGGTGAGATGCCAGCTGAGATTGGAAAACTTCAAAATCTCCAAATCATTTTAGACCTTAGTTACAATAATCTCTCAGGTCTCATCCCACCTTCTCTTGGGACACAGTCAAAGTTAGAAGCTCTTGATCTTTCCCACAATCGACTAACTGGAGAAGTCCCTCCACAAATTGGGGAAATGAGCAGTTTGGGAAAGCTTGATCTCTCTTACAACAACCTTCAAGGAAAATTGGATAAGCAGTTTTCCCGCTGGCCAGACCAGGCATTTGAAGGAAACCTACATCTTTGTGGAAGCCCTCTTGAGAGCTGCCACCGAAATGACGACTCTGGGAATGCAGGCCTAAATGAATCAACAGTAGTGATAATCTCTTCCCTTTCAACTATAGCTGCAATTGCACTTCTGATACTCGCAGTTAGAATCTTTTCCAAAAACAAGCAAGAATTTTGCAGGAAAGCCAGTGAAGTGAATTATGTTTACTCTTCTTCTTCATCACAAGCACAGAGAAGACCGCTGTTCCAACTAAATGCAGCTGGAAATAGAGATCTCAGATGGGAAGACATCATGGATGCCACGAACAATCTAAGTGAGGACTTCATGATTGGCTCAGGCGGTTCAGGGAAAATCTACAAAGCTGAATTGGCATCTGGAGAGACTGTGGCTGTCAAGAAGATTTCATCAAAAGATGAATTTCTGTTAAACAAAAGCTTCATCAGAGAAGTTAAGACACTAGGGAGGATTAGGCACAGGCATCTGGTGAAGCTAATAGGATATTGTAGCAATAGAAACAAAGAAGCAGGTTGGAATCTGTTGATATATGAGTACATGGAGAATGGGAGTGTTTGGGATTGGCTTCACGGGAAACCAGGCAAGGAGAGCAAAGTAAAGAGCAGCCTTGATTGGGAGACAAGGTTCAAAATTGCTGTAGGATTAGCTCAAGGAGTGGAATACCTGCATCACGATTGTGTCCCAAAGATCCTTCACAGGGACATCAAATCCAGCAACCTGTTGCTAGACTCAAAAATGGAGGCACACTTGGGAGATTTTGGACTGGCAAAATCACTAACCGAGAATTATGACTCTAATACTGAGTCTAATTCTTGGTTTGCTGGCTCTTATGGCTACATAGCTCCAGAGTATGCATACTCCCTACAGGCAACAGAAAAAAGTGACGTTTACAGCATGGGAATAGTTTTCATGGAACTTGTTAGTGGTAAAATGCCAACAAATGAAATTTTTGGAGATGAGATGAACATGGTGAGATGGGTAGAAATGCACGTGGATAAGCATGGCTTTGCCGGTGAGGAATTGATAGATCCTGAATTGAAACCTCTTTTACCTGATGAAGAGTACGCTGCATTCAAAGTGCTTGAGATAGCCTTACAATGCACAAAAGCTACACCACACGAGAGGCCATCTTCAAGGAAAGCATGCGATCTTCTCCTCCATGTGTTCAACAACAGGATGATGAACTTTGAGAAGAAGAATTTGGAATATTACAAATGA 3822 0.4354 MPQIMRFSTLVVVLLFCFSPTLVVLGLGYSDHTTLRVLLEVKKSFVQDPRNVLSDWSEDNIDYCSWRGVSCELNSDSNSISNSLDGDSMQVVGLNLSDSSLTGSVSPSLGRLKNLLHLDLSSNSLTGPIPPNLSNLTSLESLLLFSNQLTGHIPKEFGSLKSLRVMRLGDNALTGRIPASLANLNNLVNLGLASCGLTGSIPSQLGQLKLMENLILQDNELMGPIPTELGNCSSLTIFTAANNKLNGSIPSELGRLSNLQILNFANNSISGKIPSQLGNMSQLVYLNFMGNQLEGTIPPSLAQLGNLQNLDFSMNNFSGGIPEELGNLGELAYLVLSGNNLNGVIPRTICSNATSLEHLMLSESGLHGEIPAELSQCQQLMQLDLSNNALNGSIPLELYGLLRLTDLLLNNNSLVGSISPFIGNLSGLQTLALFHNNLEGVLPREIGMLGKLEILYLYDNQLSGAIPVGIGNCSSLQMIDFFGNRFSGEIPVTIGRLKELNFLHLRQNELVGAIPATLGNCHKLNILDLADNQLSGAIPATFGFLKELQQLMLYNNSLEGNLPHQLITVANLTRVNLSKNRLNGSIAALCSSQSFLSFDVTDNEFDGEIPSQMGNSPSLERLRLGNNKFSGEIPRTLGKIRDLSLLDLSGNSLTGPIPAELSLCNKLAYIDLNSNFLFGQIPSWLGSLSELGELKLSSNNFSGPLPLGLFKCSKLLVLSLNDNSLNGSLPSDIGELANLNVLRLDRNKFSGPIPLEIGKLIKLYELRLSRNGFHGEMPAEIGKLQNLQIILDLSYNNLSGLIPPSLGTQSKLEALDLSHNRLTGEVPPQIGEMSSLGKLDLSYNNLQGKLDKQFSRWPDQAFEGNLHLCGSPLESCHRNDDSGNAGLNESTVVIISSLSTIAAIALLILAVRIFSKNKQEFCRKASEVNYVYSSSSSQAQRRPLFQLNAAGNRDLRWEDIMDATNNLSEDFMIGSGGSGKIYKAELASGETVAVKKISSKDEFLLNKSFIREVKTLGRIRHRHLVKLIGYCSNRNKEAGWNLLIYEYMENGSVWDWLHGKPGKESKVKSSLDWETRFKIAVGLAQGVEYLHHDCVPKILHRDIKSSNLLLDSKMEAHLGDFGLAKSLTENYDSNTESNSWFAGSYGYIAPEYAYSLQATEKSDVYSMGIVFMELVSGKMPTNEIFGDEMNMVRWVEMHVDKHGFAGEELIDPELKPLLPDEEYAAFKVLEIALQCTKATPHERPSSRKACDLLLHVFNNRMMNFEKKNLEYYK* 1274
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Phac2g02896 1273 SMART LRR_typ_2 160 184 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 256 280 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 425 448 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 833 864 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 136 159 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 736 760 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 545 569 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 112 135 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 784 809 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 497 521 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 328 352 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 688 712 IPR003591 -
Phac2g02896 1273 SMART LRR_typ_2 449 473 IPR003591 -
Phac2g02896 1273 Gene3D Ribonuclease Inhibitor 208 383 IPR032675 -
Phac2g02896 1273 FunFam LRR receptor-like serine/threonine-protein kinase ERECTA 31 205 - -
Phac2g02896 1273 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 297 396 - -
Phac2g02896 1273 Pfam Protein kinase domain 972 1250 IPR000719 GO:0004672|GO:0005524|GO:0006468
Phac2g02896 1273 Pfam Leucine rich repeat N-terminal domain 36 71 IPR013210 -
Phac2g02896 1273 ProSiteProfiles Protein kinase domain profile. 967 1258 IPR000719 GO:0004672|GO:0005524|GO:0006468
Phac2g02896 1273 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 928 1047 - -
Phac2g02896 1273 Gene3D Phosphorylase Kinase; domain 1 927 1047 - -
Phac2g02896 1273 PANTHER RECEPTOR-LIKE PROTEIN 55 624 1250 - -
Phac2g02896 1273 FunFam Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 210 281 - -
Phac2g02896 1273 SUPERFAMILY L domain-like 310 655 - -
Phac2g02896 1273 PRINTS Leucine-rich repeat signature 833 846 - -
Phac2g02896 1273 PRINTS Leucine-rich repeat signature 812 825 - -
Phac2g02896 1273 SUPERFAMILY Protein kinase-like (PK-like) 953 1253 IPR011009 -
Phac2g02896 1273 SUPERFAMILY RNI-like 93 415 - -
Phac2g02896 1273 Pfam Leucine Rich Repeat 114 136 IPR001611 GO:0005515
Phac2g02896 1273 FunFam Leucine-rich repeat receptor-like protein kinase 1048 1270 - -
Phac2g02896 1273 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 588 880 - -
Phac2g02896 1273 Gene3D Ribonuclease Inhibitor 384 542 IPR032675 -
Phac2g02896 1273 Gene3D Ribonuclease Inhibitor 543 880 IPR032675 -
Phac2g02896 1273 SMART serkin_6 967 1258 IPR000719 GO:0004672|GO:0005524|GO:0006468
Phac2g02896 1273 ProSitePatterns Serine/Threonine protein kinases active-site signature. 1098 1110 IPR008271 GO:0004672|GO:0006468
Phac2g02896 1273 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 491 587 - -
Phac2g02896 1273 FunFam Uncharacterized protein 397 490 - -
Phac2g02896 1273 ProSitePatterns Protein kinases ATP-binding region signature. 973 996 IPR017441 GO:0005524
Phac2g02896 1273 SUPERFAMILY L domain-like 594 873 - -
Phac2g02896 1273 Gene3D Transferase(Phosphotransferase) domain 1 1048 1271 - -
Phac2g02896 1273 Gene3D Ribonuclease Inhibitor 33 205 IPR032675 -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Phac2g02896 Phac-Chr2 30754972 30759973 Dispersed/Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Phac2g02896 37 713 Receptor kinase-like Gene Family AT1G17750 36.457 2.73e-100 343
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XI-1 Phac2g02896 Pkinase 1.6e-44 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Phac2g02896 - - gmx:100801889 2115.5